Lingzhi Wang

Collaboration Map View Statistics Email Alert RSS Feed

Full Name

Lingzhi Wang

Variants

Wang Lingzhi
Wang, L.Z.
Wang, L.-Z.
Wang, L.

Main Affiliation

PHARMACY
CANCER SCIENCE INSTITUTE OF SINGAPORE

Faculty

FAC OF SCIENCE
SPECIALITY RESEARCH INSTITUTES/CENTRES

csiwl@nus.edu.sg

Other emails

csiwl@nus.edu.sg
phcwl@nus.edu.sg

Refined By:

File Format: Adobe PDF

Policy: Closed

Author: Ho, Paul Chi-Lui

Results 1-2 of 2 (Search time: 0.003 seconds).

Refman EndNote Bibtex RefWorks Excel CSV PDF Send via email

		Issue Date	Title	Author(s)
	1	10-Oct-2016	A novel combinatorial strategy using Seliciclib (R) and Belinostat (R) for eradication of non-small cell lung cancer via apoptosis induction and BID activation	Ong, Pei-Shi ; Wang, Lingzhi ; Chia, Deborah Miao-Hui; Seah, Jolyn Yu-Xin; Kong, Li-Ren ; Thuya, Win-Lwin ; Chinnathambi, Arunachalam; Lau, Jie-Ying Amelia ; Wong, Andrea Li-Ann ; Yong, Wei-Peng ; Yang, Daiwen ; Ho, Paul Chi-Lui ; Sethi, Gautam ; Goh, Boon-Cher
	2	28-Mar-2018	Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling	Wang, Lingzhi ; Syn, Nicholas Li-Xun; Subhash, Vinod Vijay; Any, Yijia; Thuya, Win Lwin ; Cheow, Esther Sok Hwee ; Kong, Li Ren ; Yu, Fenggang ; Peethala, Praveen C. ; Wong, Andrea Li-Ann ; Laljibhai, Hirpara J. ; Chinnathambi, Arunachalam; Ong, Pei Shi ; Ho, Paul Chi-Lui ; Sethi, Gautam ; Yong, Wei Peng ; Goh, Boon Cher